Jennifer C Palmer

Summary

Affiliation: University of Bristol
Country: UK

Publications

  1. ncbi Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β
    Jennifer C Palmer
    Dementia ResearchGroup, School of Clinical Sciences, University of Bristol, Frenchay Hospital, Bristol, UK
    J Alzheimers Dis 29:853-61. 2012
  2. ncbi Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta
    Jennifer C Palmer
    Dementia Research Group, Frenchay Hospital, Bristol, United Kingdom
    Am J Pathol 175:262-70. 2009
  3. ncbi Endothelin-converting enzyme-1 in Alzheimer's disease and vascular dementia
    J C Palmer
    Clinical Science at North Bristol, University of Bristol, Dementia Research Group, Frenchay Hospital, Bristol, UK
    Neuropathol Appl Neurobiol 36:487-97. 2010
  4. ncbi Endothelin receptor antagonists: potential in Alzheimer's disease
    Jennifer Palmer
    Dementia Research Group, Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Frenchay Hospital, Bristol BS16 1LE, United Kingdom
    Pharmacol Res 63:525-31. 2011

Detail Information

Publications4

  1. ncbi Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β
    Jennifer C Palmer
    Dementia ResearchGroup, School of Clinical Sciences, University of Bristol, Frenchay Hospital, Bristol, UK
    J Alzheimers Dis 29:853-61. 2012
    ..024). These findings provide evidence of overactivity of the endothelin system in AD, further supporting the suggestion that endothelin receptor antagonists may be of value for the treatment of this disease...
  2. ncbi Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta
    Jennifer C Palmer
    Dementia Research Group, Frenchay Hospital, Bristol, United Kingdom
    Am J Pathol 175:262-70. 2009
    ..Our findings suggest that endothelin-1 receptor antagonists, already licensed for treating other diseases, could be of benefit in AD therapies...
  3. ncbi Endothelin-converting enzyme-1 in Alzheimer's disease and vascular dementia
    J C Palmer
    Clinical Science at North Bristol, University of Bristol, Dementia Research Group, Frenchay Hospital, Bristol, UK
    Neuropathol Appl Neurobiol 36:487-97. 2010
    ..In vitro, expression of ECE-2 was upregulated by Aβ. Our aims for this study were to examine expression of ECE-1 (which has 57% homology with ECE-2) in temporal cortex from patients with AD, vascular dementia (VaD) and controls...
  4. ncbi Endothelin receptor antagonists: potential in Alzheimer's disease
    Jennifer Palmer
    Dementia Research Group, Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Frenchay Hospital, Bristol BS16 1LE, United Kingdom
    Pharmacol Res 63:525-31. 2011
    ....